Table 5.

Comparison of postoperative complications and incidence of re-injection of anti-VEGF medications in the two groups [n; Percentage (%)]

	UCP group (%)	AGV group(%)	P
n, (%)	40	40
Hypotony	0(0%)	6(15%)	0.026
Hyphema	1(2.5%)	3(7.5%)	0.615
Conjunctival hyperemia	10(25%)	12 (30%)	0.803
Corneal edema	6(15%)	8(20%)	0.770
Tube obstruction	0(0%)	4(10%)	0.116
Choroidal effusion	1(2.5%)	5(12.5%)	0.201
Suprachoroidal hemorrhage	0(0%)	2(5%)	0.494
Uveitis	0(0%)	3(7.5%)	0.241
Anti-VEGF medications	3(7.5%)	4(10%)	> 0.05
Valve exposure	0(%)	3(7.5%)	0.241

UCP = Ultrasound cycloplasty; AGV = Ahmed glaucoma valve; VEGF = Vascular endothelial growth factor